DNA interstrand cross-linking and TP53 status as determinants of tumour cell sensitivity in vitro to the antibody-directed enzyme prodrug therapy ZD2767-Reference-Cited by-同舟云学术

DNA interstrand cross-linking and TP53 status as determinants of tumour cell sensitivity in vitro to the antibody-directed enzyme prodrug therapy ZD2767

Published:2002-07 Issue:11 Volume:38 Page:1543-1552
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Monks Noel R.,Blakey David C.,East Simon J.,Dowell Robert I.,Calvete Joanne A.,Curtin Nicola J.,Arris Christine E.,Newell David R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Trends in drug targeting for cancer;Singh;Drug Delivery,1996

2. Novel therapeutic strategies to selectively kill cancer cells;Panchal;Biochem. Pharmacol.,1988

3. Antibody directed enzymes revive anti-cancer prodrugs concept;Bagshawe;Br. J. Cancer,1987

4. Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT);Springer;J. Med. Chem.,1995

5. ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumour regressions in colorectal tumour xenografts;Blakey;Cancer Res.,1996

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracellular Pharmacokinetics of Activated Drugs in a Prodrug–Enzyme–Ultrasound System: Evaluations on ZD2767P+CPG2+US;ACS Medicinal Chemistry Letters;2024-04-04

2. Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy;Biomedicine & Pharmacotherapy;2023-10

3. Development of ZD2767P–carboxypeptidase G2–ultrasound therapy against cisplatin-resistant cancer;Frontiers in Oncology;2023-05-18

4. Ultrasonically Enhanced ZD2767P–Carboxypeptidase G2 Deactivates Cisplatin-Resistant Human Lung Cancer Cells;Oxidative Medicine and Cellular Longevity;2022-11-04

5. Ultrasound Enhances ZD2767P–Carboxypeptidase G2 against Chemoresistant Ovarian Cancer Cells by Altering the Intracellular Pharmacokinetics of ZD2767D;Molecular Pharmaceutics;2020-04-17